移植前C3d结合型供者特异性抗HLA抗体与肾移植失败风险增加无关
本研究利用C3d单抗原微珠法检测567例移植前DSA阳性血清,其中97例(17%)含C3d结合型DSA。移植后10年,C3d结合型与非结合型DSA患者的死亡删失校正移植肾存活率分别为60%和64%(HR 1.02,95%CI 0.70-1.48,P=0.93),无DSA患者为78%。结论认为移植前DSA的C3d结合能力与移植肾失败风险增加无关。
要点
- 移植前C3d结合型DSA并不增加移植肾失败风险。
- C3d结合型DSA患者10年校正存活率60%,非结合型为64%。
- 无DSA患者10年存活率78%,提示DSA阳性本身仍影响预后。
核心结论
- 移植前DSA的C3d结合能力与移植肾失败风险增加无关。
研究设计与样本
- 对567例移植前DSA阳性血清样本进行C3d单抗原微珠法检测,并分析移植后10年结局。
主要发现
- 567例中97例(17%)含至少一种C3d结合型DSA,470例(83%)为非C3d结合型DSA。
- 10年死亡删失校正移植肾存活率:C3d结合型60%,非结合型64%,无DSA 78%。
- C3d结合型对比非结合型的风险比HR为1.02(95%CI 0.70-1.48,P=0.93)。
临床怎么用
- 移植前C3d结合型DSA检测结果不应单独作为移植禁忌或风险分层依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background Complement-fixing antibodies against donor HLA are considered a contraindication for kidney transplant. A modification of the IgG single-antigen bead (SAB) assay allows detection of anti-HLA antibodies that bind C3d. Because early humoral graft rejection is considered to be complement mediated, this SAB-based technique may provide a valuable tool in the pretransplant risk stratification of kidney transplant recipients.Methods Previously, we established that pretransplant donor-specific anti-HLA antibodies (DSAs) are associated with increased risk for long-term graft failure in complement-dependent cytotoxicity crossmatch-negative transplants. In this study, we further characterized the DSA-positive serum samples using the C3d SAB assay.Results Among 567 pretransplant DSA-positive serum samples, 97 (17%) contained at least one C3d-fixing DSA, whereas 470 (83%) had non-C3d-fixing DSA. At 10 years after transplant, patients with C3d-fixing antibodies had a death-censored, covariate-adjusted graft survival of 60%, whereas patients with non-C3d-fixing DSA had a graft survival of 64% (hazard ratio, 1.02; 95% confidence interval, 0.70 to 1.48 for C3d-fixing DSA compared with non-C3d-fixing DSA; P=0.93). Patients without DSA had a 10-year graft survival of 78%.Conclusions The C3d-fixing ability of pretransplant DSA is not associated with increased risk for graft failure.
引用
- Kamburova EG, Wisse BW, Joosten I, et al. Pretransplant C3d-Fixing Donor-Specific Anti-HLA Antibodies Are Not Associated with Increased Risk for Kidney Graft Failure. J Am Soc Nephrol. 2018. PMID: 30049681. doi:10.1681/ASN.2018020205
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。